ALLO
Price
$1.26
Change
-$0.05 (-3.82%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
293.27M
105 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$4.04
Change
-$0.13 (-3.12%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.1B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALLO vs RXRX

Header iconALLO vs RXRX Comparison
Open Charts ALLO vs RXRXBanner chart's image
Allogene Therapeutics
Price$1.26
Change-$0.05 (-3.82%)
Volume$9.73K
Capitalization293.27M
Recursion Pharmaceuticals
Price$4.04
Change-$0.13 (-3.12%)
Volume$202.34K
Capitalization2.1B
ALLO vs RXRX Comparison Chart in %
ALLO
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALLO vs. RXRX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ALLO: $1.30 vs. RXRX: $4.16)
Brand notoriety: ALLO and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 100% vs. RXRX: 51%
Market capitalization -- ALLO: $293.27M vs. RXRX: $2.1B
ALLO [@Biotechnology] is valued at $293.27M. RXRX’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than RXRX.

Price Growth

ALLO (@Biotechnology) experienced а +5.24% price change this week, while RXRX (@Biotechnology) price change was -11.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

ALLO is expected to report earnings on Mar 04, 2026.

RXRX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.1B) has a higher market cap than ALLO($293M). RXRX (-38.462) and ALLO (-38.732) have similar YTD gains . ALLO has higher annual earnings (EBITDA): -223.22M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. ALLO (273M). ALLO has less debt than RXRX: ALLO (79.2M) vs RXRX (88.1M). RXRX has higher revenues than ALLO: RXRX (64.5M) vs ALLO (0).
ALLORXRXALLO / RXRX
Capitalization293M2.1B14%
EBITDA-223.22M-583.64M38%
Gain YTD-38.732-38.462101%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash273M525M52%
Total Debt79.2M88.1M90%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLORXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 23 days ago
81%
Bullish Trend 24 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACUT0.870.01
+1.60%
Accustem Sciences Inc.
MPNGY25.440.02
+0.08%
MEITUAN
AUKNY24.82N/A
N/A
Auckland International Airport Ltd.
SLOIF41.78N/A
N/A
Soitec, Bernin
QQFSF0.06N/A
N/A
Qinqin Foodstuffs Group Cayman Co Ltd